Navigation Links
Beijing 2008 Olympic Games Vegetable Supplier Considering Kiwa as a Supplier of Bio-Fertilizers & Kiwa Announces CEO Interview with

BEIJING and CLAREMONT, Calif., Feb. 27 /Xinhua-PRNewswire-FirstCall/ -- Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) announced that Kiwa is being considered as a supplier of bio-fertilizers for the vegetable farms selected to supply the Olympic Village and hotels during the 2008 Olympics. Kiwa also announced that Wei Li, Chairman of the Board and CEO of the Company, would participate in an interview with March 5, 2008.

A vegetable planting-base administrated by Beijing Lufulong Vegetable Corp. was designated for the Beijing 2008 Olympic Games Vegetable Planting-Base by the Organizing Committee for the Games. The vegetable-planting base will be in charge of supplying vegetables to the Olympic Village and hotels during the Beijing 2008 Olympic Games.

From Feb. 22 to Feb. 25, the CEO of Kiwa, Mr. Wei Li; the General Manager of Kiwa Shangdong, Mr. Yunlong Zhang; and the Director of Kiwa-CAU R&D Center and Professor of China Agricultural University, Prof. Qi Wang were invited to examine the farms in Yanqing County designated for growing vegetables for the Olympics. Subsequently, three of Kiwa's fertilizer products including refined organic fertilizer were selected for field tests in the 30 vegetable planting greenhouses of Beijing Yanqing Vegetable Farms. According to the planting test schedule results will come out around Mar. 15.

The Director of Kiwa-CAU R&D Center and Professor of China Agricultural University, Prof. Qi Wang stated, "Based on the specifics for growing vegetables for visitors to the Olympic, we believe Kiwa's products are in a strong competitive position in terms of both effectiveness and price. We are confident that our products will be accepted by Beijing Yanqing Vegetable Farms' management and will become the Beijing Olympic Games Vegetable Planting Base specified products." Once Kiwa's products are approved for growing vegetables for the Olympics it is expected that their use will be promoted for the much larger vegetable growing areas of Beijing Yanqing Beijing Lu Fu Long Vegetable Corp.

The interview will cover the company's business plan to report profitable revenue in 2008 and will review:
(1) Expectations for manufacturing and selling 40,000 tons of bio-feeds

in 2008

(2) Marketing and manufacturing improvements leading to growth of bio-

fertilizer sales in 2008 including the development of a significant

distribution and marketing network

(3) Progress at Kiwa-China Agricultural University R & D Center

(4) Progress since the signing of a Letter of Intent with Shijiazhuang

Huaxing Animal Medicine Co., Ltd. ("Huaxing") in December 2007.

Leading to the acquisition of the factory that produces

pharmaceuticals with GMP (Good Manufacturing Process)

About Kiwa Bio-Tech Products Group Corporation

The Company develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company has acquired the rights to manufacture and market AF-01 Anti-viral Aerosol Agent for use in preventing (blocking) bird-flu disease in Chinese and international markets. The Company has excellent relations with government authorities in China and has developed several innovative, high margin products, while continuing to grow through internal and external product development. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. For more information about the Company, please review documents filed with the SEC ( or visit the Company's website at .

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward- looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

For more information, please contact:

Kiwa Bio-Tech Products Group Corporation

Yvonne Wang

Tel: +1-626-715-5855


Robert Schechter

Equity Communications

Tel: +1-212-499-6809

To be added to Kiwa Bio-Tech's corporate e-mail list for shareholders and interested investors, please send an e-mail to

SOURCE Kiwa Bio-Tech Products Group Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Kiwa Holds 2007 Annual Management Meetings and Employee Recognition Ceremonies in Beijing
2. Thermo Fisher Scientific Selected by China Doping Control Center to Supply Testing Instrumentation for the 2008 Olympic Games in Beijing
3. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
4. Bayer CropSciences Vegetable Seed Business Nunhems Acquires US Lettuce Seed Company Paragon Seed
5. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
6. Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance
7. DARA BioSciences, Inc. Announces Appointment of New Director to Board
8. Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
9. Mylan Announces Amendment to Bystolic(TM) (Nebivolol) Agreement
10. ZARS Pharma Announces Marketing Authorization of Rapydan(R) in Europe
11. NexGen Biofuels Ltd. (Nasdaq: NXGN) Announces Receipt of Nasdaq Delisting Determination
Post Your Comments:
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015 ... that management will participate in a fireside chat discussion ... New York . The discussion is ... Time. .  A replay will ... Contact:  Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate ...
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/25/2015)... Francisco, CA (PRWEB) , ... November 25, 2015 ... ... microbial genomics company uBiome, were featured on AngelList early in their initial angel ... launching an AngelList syndicate for individuals looking to make early stage investments in ...
(Date:11/24/2015)... KUALA LUMPUR, Malaysia , Nov. 24, 2015 ... the global contract research organisation (CRO) market. The ... to result in lower margins but higher volume ... With increased capacity and scale, however, margins in ... Contract Research Organisation (CRO) Market ( ...
Breaking Biology Technology:
(Date:11/20/2015)... OXFORD, Connecticut , November 20, 2015 ... biometric authentication company focused on the growing mobile commerce ... its CEO, Gino Pereira , was recently interviewed ... The interview will air on this weekend on ... Bloomberg Latin America . --> NXTD ) ...
(Date:11/19/2015)... Nov. 19, 2015  Based on its in-depth analysis ... recognizes BIO-key with the 2015 Global Frost & Sullivan ... & Sullivan presents this award to the company that ... the needs of the market it serves. The award ... and expands on customer base demands, the overall impact ...
(Date:11/19/2015)... -- Although some 350 companies are actively involved in molecular ... according to Kalorama Information. These include Roche Diagnostics, Hologic, Abbott ... of the 6.1 billion-dollar molecular testing market, according to ... Diagnostic s .    ... one company and only a handful of companies can ...
Breaking Biology News(10 mins):